JPMorgan Chase & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.76B Sell
25,659,722
-5,862,792
-19% -$630M 0.18% 114
2025
Q1
$3.18B Buy
31,522,514
+5,278,861
+20% +$533M 0.23% 97
2024
Q4
$2.34B Buy
26,243,653
+204,261
+0.8% +$18.2M 0.17% 125
2024
Q3
$2.18B Sell
26,039,392
-524,283
-2% -$43.9M 0.17% 126
2024
Q2
$2.05B Sell
26,563,675
-4,915,959
-16% -$379M 0.17% 116
2024
Q1
$2.16B Buy
31,479,634
+2,845,922
+10% +$195M 0.18% 114
2023
Q4
$1.66B Buy
28,633,712
+4,529,740
+19% +$262M 0.16% 129
2023
Q3
$1.27B Buy
24,103,972
+940,531
+4% +$49.7M 0.14% 143
2023
Q2
$1.25B Sell
23,163,441
-10,514,440
-31% -$569M 0.14% 152
2023
Q1
$1.68B Sell
33,677,881
-13,747,665
-29% -$688M 0.21% 108
2022
Q4
$2.19B Sell
47,425,546
-3,214,061
-6% -$149M 0.29% 82
2022
Q3
$1.96B Sell
50,639,607
-870,168
-2% -$33.7M 0.28% 74
2022
Q2
$1.92B Buy
51,509,775
+3,738,113
+8% +$139M 0.27% 82
2022
Q1
$2.12B Buy
47,771,662
+956,611
+2% +$42.4M 0.25% 82
2021
Q4
$1.99B Buy
46,815,051
+9,427,386
+25% +$400M 0.23% 88
2021
Q3
$1.62B Sell
37,387,665
-2,181,758
-6% -$94.7M 0.2% 110
2021
Q2
$1.69B Sell
39,569,423
-800,780
-2% -$34.2M 0.2% 106
2021
Q1
$1.56B Buy
40,370,203
+677,071
+2% +$26.2M 0.21% 103
2020
Q4
$1.43B Sell
39,693,132
-1,862,121
-4% -$66.9M 0.21% 105
2020
Q3
$1.57B Buy
41,555,253
+2,029,505
+5% +$76.6M 0.26% 72
2020
Q2
$1.39B Buy
39,525,748
+2,051,581
+5% +$72M 0.27% 72
2020
Q1
$1.22B Sell
37,474,167
-2,581,837
-6% -$84.2M 0.29% 73
2019
Q4
$1.81B Sell
40,056,004
-2,254,655
-5% -$102M 0.34% 51
2019
Q3
$1.72B Sell
42,310,659
-3,810,662
-8% -$155M 0.34% 52
2019
Q2
$1.93B Sell
46,121,321
-2,387,930
-5% -$100M 0.38% 44
2019
Q1
$1.86B Sell
48,509,251
-1,696,203
-3% -$65.1M 0.38% 42
2018
Q4
$1.77B Buy
50,205,454
+3,147,198
+7% +$111M 0.41% 40
2018
Q3
$1.81B Buy
47,058,256
+2,701,658
+6% +$104M 0.35% 47
2018
Q2
$1.45B Buy
44,356,598
+2,703,163
+6% +$88.4M 0.3% 58
2018
Q1
$1.14B Sell
41,653,435
-5,356,712
-11% -$146M 0.24% 78
2017
Q4
$1.17B Sell
47,010,147
-5,323,817
-10% -$132M 0.25% 73
2017
Q3
$1.5B Sell
52,333,964
-2,068,519
-4% -$59.4M 0.33% 51
2017
Q2
$1.51B Buy
54,402,483
+3,083,119
+6% +$85.5M 0.34% 50
2017
Q1
$1.28B Sell
51,319,364
-260,749
-0.5% -$6.48M 0.29% 60
2016
Q4
$1.12B Buy
51,580,113
+5,503,747
+12% +$119M 0.27% 77
2016
Q3
$1.1B Buy
46,076,366
+202,502
+0.4% +$4.82M 0.27% 73
2016
Q2
$1.07B Buy
45,873,864
+24,672,937
+116% +$577M 0.27% 78
2016
Q1
$399M Sell
21,200,927
-8,082,934
-28% -$152M 0.1% 216
2015
Q4
$540M Sell
29,283,861
-7,503,028
-20% -$138M 0.14% 172
2015
Q3
$604M Sell
36,786,889
-17,167,838
-32% -$282M 0.16% 147
2015
Q2
$955M Sell
53,954,727
-9,670,972
-15% -$171M 0.23% 84
2015
Q1
$1.13B Sell
63,625,699
-13,572,081
-18% -$241M 0.26% 75
2014
Q4
$1.02B Sell
77,197,780
-4,906,280
-6% -$65M 0.23% 84
2014
Q3
$970M Buy
82,104,060
+19,518,470
+31% +$231M 0.23% 84
2014
Q2
$799M Buy
62,585,590
+50,554,706
+420% +$646M 0.2% 100
2014
Q1
$163M Buy
12,030,884
+6,392,490
+113% +$86.4M 0.04% 415
2013
Q4
$67.8M Sell
5,638,394
-602,683
-10% -$7.24M 0.02% 639
2013
Q3
$73.3M Buy
6,241,077
+2,030,029
+48% +$23.8M 0.02% 622
2013
Q2
$39M Buy
+4,211,048
New +$39M 0.01% 802